Last update 25 Apr 2026

YSC001

Overview

Basic Info

Drug Type
Biological products
Synonyms
YSC-001
Target
GPCR
Action
modulators
Mechanism
GPCR modulators(G-protein coupled receptor modulators)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesEye Diseases+ [3]
Active Indication
Rheumatoid ArthritisMultiple SclerosisPemphigoid, Bullous+ [3]
Inactive Indication-
Originator Organization
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
Active Organization
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with YSC001
CTR20255067
/ RecruitingPhase 1
一项评价YSC001注射液在健康受试者中的安全性、耐受性、药代动力学和药效学特征的随机、单次给药、剂量递增的Ia期临床研究
[Translation] A randomized, single-dose, dose-escalation phase Ia clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of YSC001 injection in healthy subjects.
100 Clinical Results associated with YSC001
Login to view more data
100 Translational Medicine associated with YSC001
Login to view more data
100 Patents (Medical) associated with YSC001
Login to view more data
100 Deals associated with YSC001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 1
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
25 Dec 2025
Multiple SclerosisPreclinical
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
04 Aug 2025
Pemphigoid, BullousPreclinical
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
04 Aug 2025
Sjogren's SyndromePreclinical
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
04 Aug 2025
Systemic Lupus ErythematosusPreclinical
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
04 Aug 2025
VitiligoPreclinical
China
Yanshengchao (Beijing) Biotechnology Co., Ltd.Yanshengchao (Beijing) Biotechnology Co., Ltd.
04 Aug 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free